CreAgri’s HIDROX(R) Receives International Patent for Psoriasis and Other Inflammatory Skin Conditions

HAYWARD, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- A natural and innovative formulation of olive polyphenols for the management of inflammation based skin ailments, including Psoriasis, Eczema and other skin disorders affecting consumers around the world, has been recognized as novel by the Australian Patent Office.

Recognizing CreAgri's early efforts in the area of skin conditions that have proven refractory to treatment with immunosuppressive and glucorticoid drugs, the Australian Government has granted the California based nutraceutical leader patent protection for the use of hydroxytyrosl and olive polyphenols in the management of a number of inflammatory skin conditions, including psoriasis, eczema, allergic dermatitis and other similar disorders.

The patent, AU #2006269843 B2, "Vegetation water composition for the treatment of inflammatory skin conditions," is CreAgri's first patent addressing specifically skin disorders that relate to the correct functioning of the immune system, and is its 5th Australian patent.

"We believe in protecting innovation by the Patent system worldwide," affirms Dr. Roberto Crea, PhD., CEO of CreAgri, and inventor of the patent. "Our research of the last several year is finally being recognized as original, innovative and useful to millions of people who are suffering with diseases for which new, natural, safe and inexpensive treatment have yet to be discovered."

Skin diseases affect more than 40 million people in the United States. Psoriasis affects 8-10 million, and 30 million have eczema. Skin conditions can range from mild symptoms to extremely uncomfortable and even life-threatening.1 To these people the only options available until today were expensive and often toxic treatments, while side effects are just a way of life.

Psoriasis, an immune-mediated disease is a life-long condition and currently is treated topically with expensive and often toxic intra-dermal recombinant DNA biologics or with steroids, moisturizers, salicylic acid, anthralin, retinoids, calcipotriene, (a form of vitamin D), and coal tar. Other solutions include oral methotrexate and cyclosporine; PUVA and UVB phototherapy and laser. Each solution has its own downturn. Phototheraphy for example may contribute to skin cancer, while steroids, methotraxate and cyclosporine need a constant monitoring due to their serious side effects2, but above all none of them provides a safe, easily accessible, and non toxic long lasting solution to the problem.

"HIDROX(R), CreAgri's proprietary formulation of olive polyphenols rich in hydroxytyrosl, is the first formulation of its kind for the management of immuno-related and inflammation-based skin disorders," declares Victor Moreno, PhD, CreAgri's Senior Advisor, "For the first time consumers worldwide have an all natural remedy at their fingertips to manage a range of skin diseases originating from chronic inflammation."

"Conditions such as eczema, and psoriasis aren't only a medical emergency but they are also a social scourge"2, declares Paolo Pontoniere, VP of Corporate Communications at CreAgri, "Withdrawn from society because of their physical appearance a generation of never-exposed is moving among us. We see them on the beaches, in our offices, and in our schools, dressed head to toe oblivious to heat or sun. The Australian patent office has now recognized that HIDROX(R), CreAgri's formulation of organic olive polyphenols, may be an innovative solution for the long term management of these problems."

About HIDROX

HIDROX(R) is CREAGRI(R)'s trademarked hydroxytyrosol formulation, a powerful polyphenol scientifically recognized for its anti-inflammatory and anti-oxidant properties and efficacy in heart, skin and joint health. GRAS certified, HIDROX(R) has been subjected to a comprehensive set of clinical, safety and efficacy tests. HIDROX(R) is also covered by the largest number of international patents for applications that include hydroxytyrosol and olive polyphenol.

Excerpt from:
CreAgri's HIDROX(R) Receives International Patent for Psoriasis and Other Inflammatory Skin Conditions